{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:11:09Z","timestamp":1779300669051,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bulcan.2026.01.007","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:16:00Z","timestamp":1773231360000},"page":"806-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Les carcinomes acinaires du pancr\u00e9as, caract\u00e9ristiques cliniques et th\u00e9ranostiques"],"prefix":"10.1016","volume":"113","author":[{"given":"Andrea","family":"Marques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9o","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Dardenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Paye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4502-0058","authenticated-orcid":false,"given":"Thomas","family":"Samaille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.01.007_bib0195","article-title":"Acinar cell carcinoma of the pancreas: overview of clinicopathologic features and insights into the molecular pathology","volume":"2","author":"La Rosa","year":"2015","journal-title":"Front Med [Internet]"},{"issue":"2","key":"10.1016\/j.bulcan.2026.01.007_bib0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00428-008-0710-x","article-title":"The monoclonal anti-BCL10\u00a0antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia","volume":"454","author":"La Rosa","year":"2009","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.bulcan.2026.01.007_bib0205","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0002-9440(10)64917-6","article-title":"Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC\/\u03b2-Catenin pathway","volume":"160","author":"Abraham","year":"2002","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.bulcan.2026.01.007_bib0210","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00432-016-2264-7","article-title":"Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma","volume":"142","author":"Kruger","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2026.01.007_bib0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jjco\/hyad176","article-title":"Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment","volume":"54","author":"Ikezawa","year":"2024","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2026.01.007_bib0220","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s11605-008-0705-6","article-title":"Acinar cell carcinoma of the pancreas in the united states: prognostic factors and comparison to ductal adenocarcinoma","volume":"12","author":"Schmidt","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.bulcan.2026.01.007_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/mpa.0b013e31804bfbd3","article-title":"Acinar cell carcinoma of the pancreas: clinical analysis of 115\u00a0patients from Pancreatic Cancer Registry of Japan Pancreas Society","volume":"35","author":"Kitagami","year":"2007","journal-title":"Pancreas"},{"issue":"23","key":"10.1016\/j.bulcan.2026.01.007_bib0230","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.3390\/cancers13236121","article-title":"Survival outcome and prognostic factors for pancreatic acinar cell carcinoma: retrospective analysis from the German Cancer Registry Group","volume":"13","author":"Petrova","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.bulcan.2026.01.007_bib0235","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.hpb.2023.07.897","article-title":"Treatment characteristics and outcomes of pure Acinar cell carcinoma of the pancreas \u2013 A multicentric European study on radically resected patients","volume":"25","author":"Bellotti","year":"2023","journal-title":"HPB"},{"issue":"20","key":"10.1016\/j.bulcan.2026.01.007_bib0240","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.3390\/cancers13205095","article-title":"Clinical characteristics of resected acinar cell carcinoma of the pancreas: a Korean Multi-Institutional Study","volume":"13","author":"Shin","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bulcan.2026.01.007_bib0245","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820969447","article-title":"Clinical analysis of acinar cell carcinoma of the pancreas: a single-center experience of 45\u00a0consecutive cases","volume":"27","author":"Zhou","year":"2020","journal-title":"Cancer Control"},{"key":"10.1016\/j.bulcan.2026.01.007_bib0250","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1038\/modpathol.3800686","article-title":"Nonductal neoplasms of the pancreas","volume":"20","author":"Klimstra","year":"2007","journal-title":"Modern Pathol"},{"issue":"2","key":"10.1016\/j.bulcan.2026.01.007_bib0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019\u00a0WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"24","key":"10.1016\/j.bulcan.2026.01.007_bib0260","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1200\/JCO.2002.02.005","article-title":"Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors","volume":"20","author":"Holen","year":"2002","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.bulcan.2026.01.007_bib0265","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.surg.2008.03.006","article-title":"672\u00a0patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma","volume":"144","author":"Wisnoski","year":"2008","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.bulcan.2026.01.007_bib0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.amjsurg.2010.06.004","article-title":"Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease?","volume":"202","author":"Hartwig","year":"2011","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.bulcan.2026.01.007_bib0275","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.hpb.2018.10.014","article-title":"Underutilization of surgical resection in patients with pancreatic acinar cell carcinoma","volume":"21","author":"Landa","year":"2019","journal-title":"HPB"},{"issue":"3","key":"10.1016\/j.bulcan.2026.01.007_bib0280","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjsurg.2019.10.013","article-title":"Clinically resectable acinar cell carcinoma of the pancreas: Is there a benefit to adjuvant systemic therapy?","volume":"219","author":"Patel","year":"2020","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.bulcan.2026.01.007_bib0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MPA.0000000000001788","article-title":"Survival outcomes of acinar cell pancreatic cancer: a national cancer database analysis","volume":"50","author":"Shaib","year":"2021","journal-title":"Pancreas"},{"issue":"8","key":"10.1016\/j.bulcan.2026.01.007_bib0290","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/1751-2980.12505","article-title":"Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma","volume":"18","author":"Seo","year":"2017","journal-title":"J Digest Dis"},{"issue":"6","key":"10.1016\/j.bulcan.2026.01.007_bib0295","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.pan.2021.05.011","article-title":"Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes","volume":"21","author":"Sridharan","year":"2021","journal-title":"Pancreatology"},{"key":"10.1016\/j.bulcan.2026.01.007_bib0300","doi-asserted-by":"crossref","DOI":"10.1177\/11795549221090186","article-title":"Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature","volume":"16","author":"Xu","year":"2022","journal-title":"Clin Med Insights Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.01.007_bib0305","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MPA.0000000000001718","article-title":"Multicenter retrospective analysis of chemotherapy for advanced pancreatic acinar cell carcinoma: potential efficacy of platinum- and irinotecan-containing regimens","volume":"50","author":"Takahashi","year":"2021","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.bulcan.2026.01.007_bib0310","doi-asserted-by":"crossref","first-page":"e2400450","DOI":"10.1200\/PO-24-00450","article-title":"Clinical outcomes and molecular profiling of pancreatic acinar cell carcinoma: a retrospective study","author":"Eslinger","year":"2025","journal-title":"JCO Precis Oncol"},{"issue":"17","key":"10.1016\/j.bulcan.2026.01.007_bib0315","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-22-3724","article-title":"Comparative genomic analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) unveils new actionable genomic aberrations in PACC","volume":"29","author":"Florou","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.bulcan.2026.01.007_bib0320","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/2159-8290.CD-14-0617","article-title":"Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes","volume":"4","author":"Chmielecki","year":"2014","journal-title":"Cancer Discov"},{"issue":"33","key":"10.1016\/j.bulcan.2026.01.007_bib0325","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1200\/JCO.23.00561","article-title":"Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma","volume":"41","author":"Mandelker","year":"2023","journal-title":"JCO"},{"issue":"45","key":"10.1016\/j.bulcan.2026.01.007_bib0330","doi-asserted-by":"crossref","first-page":"e13113","DOI":"10.1097\/MD.0000000000013113","article-title":"Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib: A case report","volume":"97","author":"Li","year":"2018","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.bulcan.2026.01.007_bib0335","doi-asserted-by":"crossref","first-page":"e6718","DOI":"10.1002\/ccr3.6718","article-title":"Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2\u00a0mutation, revealed by severe panniculitis","volume":"10","author":"Lelong","year":"2022","journal-title":"Clin Case Rep"},{"issue":"4","key":"10.1016\/j.bulcan.2026.01.007_bib0340","doi-asserted-by":"crossref","first-page":"a005553","DOI":"10.1101\/mcs.a005553","article-title":"Successful BRAF\/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinoma","volume":"6","author":"Busch","year":"2020","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"8","key":"10.1016\/j.bulcan.2026.01.007_bib0345","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/MPA.0000000000000190","article-title":"DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance","volume":"43","author":"Liu","year":"2014","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.bulcan.2026.01.007_bib0350","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2017.11.009","article-title":"Prevalence of microsatellite instability in intraductal papillary mucinous neoplasms of the pancreas","volume":"154","author":"Lupinacci","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bulcan.2026.01.007_bib0355","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2026.01.007_bib0360","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1\u00a0expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.bulcan.2026.01.007_bib0365","doi-asserted-by":"crossref","first-page":"NP24","DOI":"10.1177\/0300891620980792","article-title":"Efficacy of chemotherapy combined with toripalimab in PD-L1\u2013positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report","volume":"107","author":"Xu","year":"2021","journal-title":"Tumori"},{"issue":"7","key":"10.1016\/j.bulcan.2026.01.007_bib0370","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00432-024-05841-z","article-title":"Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma","volume":"150","author":"Merz","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2026.01.007_bib0375","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41379-019-0373-y","article-title":"RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas","volume":"33","author":"Chou","year":"2020","journal-title":"Modern Pathol"},{"key":"10.1016\/j.bulcan.2026.01.007_bib0190","article-title":"Targeting the NTRK fusion gene in pancreatic acinar cell carcinoma: a case report and review of the literature","author":"Gupta","year":"2021","journal-title":"JNCCN"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:58:05Z","timestamp":1779299885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0007455126001049"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.01.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les carcinomes acinaires du pancr\u00e9as, caract\u00e9ristiques cliniques et th\u00e9ranostiques","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}